A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial

Background and purpose: The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable. Our aim was to test a personalised treatment concept for BCR based on PSA kinetics during salvage radiotherapy (SRT) combined with prostate-sp...

Full description

Bibliographic Details
Main Authors: Adalsteinn Gunnlaugsson, Vilberg Johannesson, Elinore Wieslander, Eva Brun, Ulrika Bitzén, Olof Ståhl, Ola Bratt, Göran Ahlgren, Tomas Ohlsson, Elisabeth Kjellén, Per Nilsson
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Salvage radiotherapy
Prostate cancer
Adaptive
Prostate specific antigen
Prostate specific membrane antigen
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822000544

Internet

http://www.sciencedirect.com/science/article/pii/S2405630822000544

Similar Items